blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2937083

EP2937083 - Formulations, salts and polymorphs of transnorsertraline and uses thereof [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.02.2020
Database last updated on 27.07.2024
FormerThe patent has been granted
Status updated on  22.02.2019
FormerGrant of patent is intended
Status updated on  18.10.2018
FormerExamination is in progress
Status updated on  20.03.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Sunovion Pharmaceuticals Inc.
84 Waterford Drive
Marlborough, MA 01752 / US
[2015/44]
Inventor(s)01 / Laughlin, Sharon M.
84 Waterford Drive
Marlborough, MA 01752 / US
02 / Sizensky, Michael J.
84 Waterford Drive
Marlborough, MA 01752 / US
03 / Singh, Surendra P.
84 Waterford Drive
Marlborough, MA 01752 / US
04 / Wilkinson, Scott H.
84 Waterford Drive
Marlborough, MA 01752 / US
05 / Huang, Cai Gu
84 Waterford Drive
Marlborough, MA 01752 / US
06 / Bonasia, Philip James
84 Waterford Drive
Marlborough, MA 01752 / US
07 / D'Souza, Susan S.
207 Applebriar Lane
Marlborough, MA 01752 / US
 [2015/44]
Representative(s)Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
[N/P]
Former [2019/13]Elkington & Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
Former [2015/44]Cooke, Richard Spencer, et al
Elkington and Fife LLP
Patents Department
3-4 Holborn Circus
London EC1N 2HA / GB
Application number, filing date15150813.203.12.2010
[2015/44]
Priority number, dateUS20090266864P04.12.2009         Original published format: US 266864 P
[2015/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2937083
Date:28.10.2015
Language:EN
[2015/44]
Type: B1 Patent specification 
No.:EP2937083
Date:27.03.2019
Language:EN
[2019/13]
Search report(s)(Supplementary) European search report - dispatched on:EP01.09.2015
ClassificationIPC:A61K31/135, A61K31/70, A61P25/00, A61K9/20
[2015/44]
CPC:
A61K31/135 (EP,IL,KR,US); A61K31/70 (IL,KR); A61K9/2018 (EP,IL,KR,US);
A61K9/4858 (EP,IL,KR,US); A61P15/08 (EP); A61P15/12 (EP);
A61P25/00 (EP); A61P25/04 (EP); A61P25/14 (EP);
A61P25/18 (EP); A61P25/20 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P25/30 (EP);
A61P29/00 (EP); A61P3/04 (EP); A61P9/00 (EP);
C07C211/42 (IL,US); A61K2300/00 (IL,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/40]
Former [2015/44]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:Formulierungen, Salze und Polymorphe aus Transnorsertralin und Verwendungen davon[2015/44]
English:Formulations, salts and polymorphs of transnorsertraline and uses thereof[2015/44]
French:Formulations, sels et polymorphes de transnorsertraline et leurs utilisations[2015/44]
Examination procedure17.06.2016Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time
26.08.2016Amendment by applicant (claims and/or description)
26.08.2016Examination requested  [2016/40]
15.03.2017Despatch of a communication from the examining division (Time limit: M06)
21.09.2017Reply to a communication from the examining division
13.03.2018Despatch of a communication from the examining division (Time limit: M02)
08.05.2018Reply to a communication from the examining division
19.10.2018Communication of intention to grant the patent
14.02.2019Fee for grant paid
14.02.2019Fee for publishing/printing paid
14.02.2019Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP10835166.9  / EP2506842
Opposition(s)03.01.2020No opposition filed within time limit [2020/11]
Request for further processing for:The application is deemed to be withdrawn due to non-payment of the examination fee
26.08.2016Request for further processing filed
26.08.2016Full payment received (date of receipt of payment)
Request granted
23.09.2016Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
26.08.2016Request for further processing filed
26.08.2016Full payment received (date of receipt of payment)
Request granted
23.09.2016Decision despatched
The application is deemed to be withdrawn due to non-payment of designation fees
TR, SM, SK, SI, SE, RS, RO, PT, PL, NO, NL, MT, MK, MC, LV, LU, LT, IT, IS, IE, HU, HR, GR, GB, FR, FI, ES, EE, DK, DE, CZ, CY, CH, BG, BE, AT, AL
26.08.2016Request for further processing filed
26.08.2016Full payment received (date of receipt of payment)
Request granted
23.09.2016Decision despatched
26.08.2016Request for further processing filed
26.08.2016Full payment received (date of receipt of payment)
Request granted
23.09.2016Decision despatched
Fees paidRenewal fee
12.01.2015Renewal fee patent year 03
12.01.2015Renewal fee patent year 04
12.01.2015Renewal fee patent year 05
10.12.2015Renewal fee patent year 06
13.12.2016Renewal fee patent year 07
27.12.2017Renewal fee patent year 08
31.12.2018Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.12.2010
AL27.03.2019
AT27.03.2019
CY27.03.2019
CZ27.03.2019
DK27.03.2019
EE27.03.2019
ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
MC27.03.2019
MK27.03.2019
MT27.03.2019
NL27.03.2019
PL27.03.2019
RO27.03.2019
RS27.03.2019
SE27.03.2019
SI27.03.2019
SK27.03.2019
SM27.03.2019
TR27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
LU03.12.2019
BE31.12.2019
[2022/31]
Former [2021/34]HU03.12.2010
AL27.03.2019
AT27.03.2019
CY27.03.2019
CZ27.03.2019
DK27.03.2019
EE27.03.2019
ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
MC27.03.2019
MT27.03.2019
NL27.03.2019
PL27.03.2019
RO27.03.2019
RS27.03.2019
SE27.03.2019
SI27.03.2019
SK27.03.2019
SM27.03.2019
TR27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
LU03.12.2019
BE31.12.2019
Former [2021/33]HU03.12.2010
AL27.03.2019
AT27.03.2019
CY27.03.2019
CZ27.03.2019
DK27.03.2019
EE27.03.2019
ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
MC27.03.2019
NL27.03.2019
PL27.03.2019
RO27.03.2019
RS27.03.2019
SE27.03.2019
SI27.03.2019
SK27.03.2019
SM27.03.2019
TR27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
LU03.12.2019
BE31.12.2019
Former [2021/26]AL27.03.2019
AT27.03.2019
CY27.03.2019
CZ27.03.2019
DK27.03.2019
EE27.03.2019
ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
MC27.03.2019
NL27.03.2019
PL27.03.2019
RO27.03.2019
RS27.03.2019
SE27.03.2019
SI27.03.2019
SK27.03.2019
SM27.03.2019
TR27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
LU03.12.2019
BE31.12.2019
Former [2020/51]AL27.03.2019
AT27.03.2019
CZ27.03.2019
DK27.03.2019
EE27.03.2019
ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
MC27.03.2019
NL27.03.2019
PL27.03.2019
RO27.03.2019
RS27.03.2019
SE27.03.2019
SI27.03.2019
SK27.03.2019
SM27.03.2019
TR27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
LU03.12.2019
BE31.12.2019
Former [2020/46]AL27.03.2019
AT27.03.2019
CZ27.03.2019
DK27.03.2019
EE27.03.2019
ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
MC27.03.2019
NL27.03.2019
PL27.03.2019
RO27.03.2019
RS27.03.2019
SE27.03.2019
SI27.03.2019
SK27.03.2019
SM27.03.2019
TR27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
LU03.12.2019
Former [2020/39]AL27.03.2019
AT27.03.2019
CZ27.03.2019
DK27.03.2019
EE27.03.2019
ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
MC27.03.2019
NL27.03.2019
PL27.03.2019
RO27.03.2019
RS27.03.2019
SE27.03.2019
SI27.03.2019
SK27.03.2019
SM27.03.2019
TR27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
Former [2020/17]AL27.03.2019
AT27.03.2019
CZ27.03.2019
DK27.03.2019
EE27.03.2019
ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
NL27.03.2019
PL27.03.2019
RO27.03.2019
RS27.03.2019
SE27.03.2019
SI27.03.2019
SK27.03.2019
SM27.03.2019
TR27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
Former [2020/13]AL27.03.2019
AT27.03.2019
CZ27.03.2019
DK27.03.2019
EE27.03.2019
ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
NL27.03.2019
PL27.03.2019
RO27.03.2019
RS27.03.2019
SE27.03.2019
SI27.03.2019
SK27.03.2019
SM27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
Former [2020/09]AL27.03.2019
AT27.03.2019
CZ27.03.2019
DK27.03.2019
EE27.03.2019
ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
NL27.03.2019
PL27.03.2019
RO27.03.2019
RS27.03.2019
SE27.03.2019
SK27.03.2019
SM27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
Former [2020/04]AL27.03.2019
AT27.03.2019
CZ27.03.2019
EE27.03.2019
ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
NL27.03.2019
PL27.03.2019
RO27.03.2019
RS27.03.2019
SE27.03.2019
SK27.03.2019
SM27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
IS27.07.2019
PT27.07.2019
Former [2020/03]AL27.03.2019
AT27.03.2019
CZ27.03.2019
EE27.03.2019
ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
NL27.03.2019
PL27.03.2019
RO27.03.2019
RS27.03.2019
SE27.03.2019
SK27.03.2019
SM27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
PT27.07.2019
Former [2019/52]AL27.03.2019
CZ27.03.2019
EE27.03.2019
ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
NL27.03.2019
PL27.03.2019
RO27.03.2019
RS27.03.2019
SE27.03.2019
SK27.03.2019
SM27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
PT27.07.2019
Former [2019/51]AL27.03.2019
CZ27.03.2019
EE27.03.2019
ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
NL27.03.2019
RO27.03.2019
RS27.03.2019
SE27.03.2019
SK27.03.2019
SM27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
PT27.07.2019
Former [2019/49]AL27.03.2019
CZ27.03.2019
EE27.03.2019
ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
NL27.03.2019
RO27.03.2019
RS27.03.2019
SE27.03.2019
SK27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
PT27.07.2019
Former [2019/48]ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
NL27.03.2019
RS27.03.2019
SE27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
PT27.07.2019
Former [2019/47]ES27.03.2019
FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
NL27.03.2019
RS27.03.2019
SE27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
Former [2019/46]FI27.03.2019
HR27.03.2019
IT27.03.2019
LT27.03.2019
LV27.03.2019
NL27.03.2019
RS27.03.2019
SE27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
Former [2019/39]FI27.03.2019
HR27.03.2019
LT27.03.2019
LV27.03.2019
NL27.03.2019
RS27.03.2019
SE27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
Former [2019/38]FI27.03.2019
LT27.03.2019
SE27.03.2019
BG27.06.2019
NO27.06.2019
GR28.06.2019
Former [2019/37]FI27.03.2019
LT27.03.2019
SE27.03.2019
NO27.06.2019
GR28.06.2019
Former [2019/34]FI27.03.2019
LT27.03.2019
SE27.03.2019
NO27.06.2019
Former [2019/33]FI27.03.2019
LT27.03.2019
NO27.06.2019
Documents cited:Search[Y]US2001044474  (CURATOLO WILLIAM J [US], et al) [Y] 1-6,15* paragraph [0066] *;
 [XY]WO2004024669  (SEPRACOR INC [US], et al) [X] 7-15 * pages 17-18 * * pages 14,24-25 * [Y] 1-15;
 [Y]US2006257475  (ECONOMOU JULIA [US], et al) [Y] 1-6,15 * paragraphs [0030] , [0031] *;
 [XY]WO2007006003  (SEPRACOR INC [US], et al) [X] 7-15 * page 14 * * pages 29-35 * [Y] 1-15;
 [XY]WO2007115185  (SEPRACOR INC [US], et al) [X] 7-15 * pages 47-48 * [Y] 1-15;
 [XY]WO2007143267  (SEPRACOR INC [US], et al) [X] 7-15 * pages 7,19 * * pages 16,37 * [Y] 1-15;
 [XPY]WO2010132521  (SEPRACOR INC [US], et al) [XP] 1,6 * pages 22-25 * [Y] 1-15;
 [XY]  - ZHENGXU HAN ET AL, "Development of a Large-Scale Stereoselective Process for (1 R ,4 S )-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine Hydrochloride", ORGANIC PROCESS RESEARCH & DEVELOPMENT, (20070701), vol. 11, no. 4, doi:10.1021/op7000589, ISSN 1083-6160, pages 726 - 730, XP055059530 [X] 7-15 * pages 727,730 * [Y] 1-15

DOI:   http://dx.doi.org/10.1021/op7000589
by applicantUS3536809
 US3598123
 US3845770
 US3916899
 US4008719
 US5059595
 US5073543
 US5120548
 US5213738
 US5354556
 US5591767
 US5639476
 US5674533
 US5733566
 US7087785
    - KNAPMAN, K., MODERN DRUG DISCOVERIES, (2000), page 53
    - S. R. CHEMBURKAR ET AL., ORG. PIOCESS RES. DEV., (2000), vol. 4, no. 4, page 3 17
    - Remington's Pharmaceutical Sciences, MACK PUBLISHING, (1990), page 173
    - 7he United States Pharm?copei?, (1995), pages 1843 - 1844
    - Harrison's Principles of Internal Medicine, (1991), pages 93 - 98
    - WILLIAMS ET AL., J MED. CHEFII., (1999), vol. 42, pages 1481 - 1485
    - JENS T. CARSTENSEN, Drug Stability: Principles & Practice, MARCEL DEKKER, (1995), pages 379 - 80
    - BLESSING, R. H., "Program for absorption correction using Siemens CCD", SADABS
    - BLESSING R., ACTA CTYST., (1995), vol. A51, page 33
    - "International Tables for Crystallography", International Tables for Crystallography, KLUWER ACADEMIC PUBLISHERS, (1992), vol. C
    - FLACK, H. D., ACTA CTYST., (1983), vol. A39, page 876
    - GLUSKER, JENNY PICKWORTH; TRUEBLOOD, KENNETH N., Crystal Structure Analysis: A Primer, OXFORD UNIVERSITY PRESS, (1985), page 87
    - FARRUGIA, L.J., .7., APPL. CRYST., (1997), vol. 30, page 565
    - BRUNO, I. J. COLE; J. C. EDGINGTON; P. R. KESSLER; M. K. MACRAE, C. F.; MCCABE, P.; PEARSON, J.; TAYLOR, R., ACTA CRYSTALLOGR., (2002), page 858,389
    - FLACK, H. D.; BEMARDINELLI, G., ACTA C Y T., (1999), vol. A55, page 908
    - FLACK, H. D.; BEMARDINELLI, G., J. APPL. CRYST., (2000), vol. 33, page 1143
    - OTWINOWSKI, Z.; MINOR, W., METHODS ENZYMOL., (1997), vol. 276, page 307
    - MCARDLE, P. C., J. APPL. CRYST., (1996), vol. 29, page 306
    - BURLA ET AL., J. PPL. CTYST., (2005), vol. 38, page 381
    - FLACK, H. D., ACTA CRYST., (1983), vol. A39, page 876
    - FARRUGIA, LJ., J. APPL. O ST., (1997), vol. 30, page 565
    - BRUNO, 1. J. COLE; J. C. EDGINGTON; P. R. KESSLER; M. K. MACRAE; C. F. MCCABE; P. PEARSON; TAYLOR, R., ACTA CRYSTALLOGR., (2002), vol. B58, page 389
    - FLACK, H. D.; BEMARDINCLLI, G., ACTA CRYST., (1999), vol. A55, page 908
    - FLACK, H. D.; BEMARDINELLI, G.J., APPL. CYJST., (2000), vol. 33, page 1143
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.